Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 216, Issue 2, Pages 235-243
Publisher
Springer Nature
Online
2011-02-15
DOI
10.1007/s00213-011-2200-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endogenous N-Acetylaspartylglutamate (NAAG) Inhibits Synaptic Plasticity/Transmission in the Amygdala in a Mouse Inflammatory Pain Model
- (2016) Mary O Adedoyin et al. Molecular Pain
- Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus
- (2010) Rasoul Farazifard et al. BRAIN RESEARCH
- Molecular Identification ofN-Acetylaspartylglutamate Synthase and β-Citrylglutamate Synthase
- (2010) François Collard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sensing G protein-coupled receptor activation
- (2010) Manuela Ambrosio et al. NEUROPHARMACOLOGY
- Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families
- (2010) Wendy Hasenkamp et al. PSYCHIATRY RESEARCH
- Serotonin transporter, 5-HT1Areceptor, and behavior in DBA/2J mice in comparison with four inbred mouse strains
- (2009) Nina K. Popova et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The Neuroactive Peptide N-Acetylaspartylglutamate Is Not an Agonist at the Metabotropic Glutamate Receptor Subtype 3 of Metabotropic Glutamate Receptor
- (2009) M. Chopra et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR
- (2009) Anne-Cécile Fricker et al. NEUROPHARMACOLOGY
- Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495
- (2009) A.-M. Linden et al. NEUROPHARMACOLOGY
- Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice
- (2009) Kia J. Jackson et al. NEUROPHARMACOLOGY
- On the influence of baseline startle reactivity on the indexation of prepulse inhibition.
- (2008) Philipp A. Csomor et al. BEHAVIORAL NEUROSCIENCE
- Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
- (2008) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intracerebroventricular Administration of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibitors is Analgesic in Inflammatory Pain
- (2008) Tatsuo Yamamoto et al. Molecular Pain
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Phencyclidine and Dizocilpine Induced Behaviors Reduced by N-acetylaspartylglutamate Peptidase Inhibition via Metabotropic Glutamate Receptors
- (2007) Rafal T. Olszewski et al. BIOLOGICAL PSYCHIATRY
- Involvement of metabotropic glutamate receptors in excitatory amino acid and GABA release following spinal cord injury in rat
- (2003) Charles D. Mills et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started